Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16. (Q52626221)

4 May 2018

title

Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16. (English)

1 reference

4 May 2018

main subject

lymphoblastic leukemia

1 reference

4

1 reference

4 May 2018

Motohiro Kato

object named as

Motohiro Kato

3

0 references

Atsushi Manabe

27

object named as

Atsushi Manabe

1 reference

4 May 2018

author name string

Hiroyuki Takahashi

1

1 reference

4 May 2018

Ryosuke Kajiwara

2

1 reference

4 May 2018

Daisuke Tomizawa

5

1 reference

4 May 2018

Yasushi Noguchi

6

1 reference

4 May 2018

Kazutoshi Koike

7

1 reference

4 May 2018

Daisuke Toyama

8

1 reference

4 May 2018

Hiromasa Yabe

9

1 reference

4 May 2018

Michiko Kajiwara

10

1 reference

4 May 2018

Junya Fujimura

11

1 reference

4 May 2018

Manabu Sotomatsu

12

1 reference

4 May 2018

Setsuo Ota

13

1 reference

4 May 2018

Miho Maeda

14

1 reference

4 May 2018

Hiroaki Goto

15

1 reference

4 May 2018

Yoko Kato

16

1 reference

4 May 2018

Tetsuya Mori

17

1 reference

4 May 2018

Takeshi Inukai

18

1 reference

4 May 2018

Hiroyuki Shimada

19

1 reference

4 May 2018

Keitaro Fukushima

20

1 reference

4 May 2018

Chitose Ogawa

21

1 reference

4 May 2018

Atsushi Makimoto

22

1 reference

4 May 2018

Takashi Fukushima

23

1 reference

4 May 2018

Kentaro Ohki

24

1 reference

4 May 2018

Katsuyoshi Koh

25

1 reference

4 May 2018

Nobutaka Kiyokawa

26

1 reference

4 May 2018

Akira Ohara

28

1 reference

4 May 2018

publication date

27 March 2018

1 reference

4 May 2018

International Journal of Hematology

published in

1 reference

4 May 2018

https://scigraph.springernature.com/pub.10.1007/s12185-018-2440-4

exact match

0 references

cites work

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

12 December 2020

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

1 reference

12 December 2020

Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

1 reference

12 December 2020

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

1 reference

12 December 2020

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

1 reference

12 December 2020

The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study

1 reference

12 December 2020

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

1 reference

12 December 2020

How I treat relapsed childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

1 reference

12 December 2020

Acute lymphoblastic leukaemia

1 reference

12 December 2020

Relapsed childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.

1 reference

12 December 2020

Improved treatment results of children with B-cell non-Hodgkin lymphoma: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study

1 reference

12 December 2020

ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.

1 reference

12 December 2020

Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia

1 reference

12 December 2020

Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.

1 reference

12 December 2020

Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04

1 reference

12 December 2020

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

1 reference

12 December 2020

A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.

1 reference

12 December 2020

Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia

1 reference

12 December 2020

Acute Lymphoblastic Leukemia in Children.

1 reference

12 December 2020

Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy

1 reference

12 December 2020

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232

1 reference

12 December 2020

Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan

1 reference

12 December 2020

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group

1 reference

12 December 2020

1 reference

12 December 2020

Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children

1 reference

12 December 2020

Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

10.1007/S12185-018-2440-4

Identifiers

DOI

1 reference

4 May 2018

PubMed ID

29589281

1 reference

4 May 2018